These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 12130767

  • 1. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH, Hol WG.
    Science; 2002 Jul 19; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract] [Full Text] [Related]

  • 2. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K.
    Curr Opin Investig Drugs; 2006 Feb 19; 7(2):147-57. PubMed ID: 16499285
    [Abstract] [Full Text] [Related]

  • 3. Promising lead compounds for novel antiprotozoals.
    Otoguro K, Iwatsuki M, Ishiyama A, Namatame M, Nishihara-Tukashima A, Shibahara S, Kondo S, Yamada H, Omura S.
    J Antibiot (Tokyo); 2010 Jul 19; 63(7):381-4. PubMed ID: 20661239
    [No Abstract] [Full Text] [Related]

  • 4. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E, Dea-Ayuela MA, Bolás-Fernández F, Rangel M, González-Rosende ME.
    Curr Med Chem; 2010 Jul 19; 17(33):4027-51. PubMed ID: 20939823
    [Abstract] [Full Text] [Related]

  • 5. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR, Kelly JM.
    Expert Rev Mol Med; 2009 Oct 29; 11():e31. PubMed ID: 19863838
    [Abstract] [Full Text] [Related]

  • 6. Trypanosomes at the gates.
    Cross GA.
    Science; 2005 Jul 15; 309(5733):355. PubMed ID: 16020696
    [No Abstract] [Full Text] [Related]

  • 7. Parasitology: Triple genome triumph.
    Butler D.
    Nature; 2005 Jul 21; 436(7049):337. PubMed ID: 16034405
    [No Abstract] [Full Text] [Related]

  • 8. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V, Chontzopoulou E, Moschovou K, Pavlos D, Mavromoustakos T, Papanastasiou IP.
    Molecules; 2021 Jul 30; 26(15):. PubMed ID: 34361781
    [Abstract] [Full Text] [Related]

  • 9. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
    Ferrins L, Sharma A, Thomas SM, Mehta N, Erath J, Tanghe S, Leed SE, Rodriguez A, Mensa-Wilmot K, Sciotti RJ, Gillingwater K, Pollastri MP.
    PLoS Negl Trop Dis; 2018 Nov 30; 12(11):e0006834. PubMed ID: 30475800
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and in vitro antiprotozoal activities of water-soluble, inexpensive 3,7-bis(dialkylamino)phenoxazin-5-ium derivatives.
    Ge JF, Arai C, Kaiser M, Wittlin S, Brun R, Ihara M.
    J Med Chem; 2008 Jun 26; 51(12):3654-8. PubMed ID: 18476684
    [Abstract] [Full Text] [Related]

  • 11. In vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease.
    Abdel-Sattar E, Maes L, Salama MM.
    Phytother Res; 2010 Sep 26; 24(9):1322-8. PubMed ID: 20127723
    [Abstract] [Full Text] [Related]

  • 12. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M, Deng Y, Zhu X, He S, Pandharkar T, Drew ME, Navarro-Vázquez A, Anklin C, Gil RR, Doskotch RW, Werbovetz KA, Kinghorn AD.
    Bioorg Med Chem Lett; 2011 May 01; 21(9):2606-10. PubMed ID: 21474310
    [Abstract] [Full Text] [Related]

  • 13. [Rational concepts and the study of active molecules against various trypanosomiases].
    Périé J, de Albuquerque C, Blonski C, Chauvière G, Gefflaut T, Page P, Trinquier M, Willson M.
    Bull Soc Pathol Exot; 1994 May 01; 87(5):353-61. PubMed ID: 7496200
    [Abstract] [Full Text] [Related]

  • 14. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O, Persson L, Rentala M.
    Amino Acids; 2007 Aug 01; 33(2):359-66. PubMed ID: 17610127
    [Abstract] [Full Text] [Related]

  • 15. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
    Benaim B, Garcia CR.
    Trop Biomed; 2011 Dec 01; 28(3):471-81. PubMed ID: 22433874
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC, Mackey Z, Hansell E, Doyle P, Gut J, Caffrey CR, Lehrman J, Rosenthal PJ, McKerrow JH, Chibale K.
    J Med Chem; 2004 Jun 03; 47(12):3212-9. PubMed ID: 15163200
    [Abstract] [Full Text] [Related]

  • 17. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M, Mäser P, Tadoori LP, Ioset JR, Brun R.
    PLoS One; 2015 Jun 03; 10(8):e0135556. PubMed ID: 26270335
    [Abstract] [Full Text] [Related]

  • 18. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K.
    Chem Pharm Bull (Tokyo); 2016 Jun 03; 64(7):656-67. PubMed ID: 27373622
    [Abstract] [Full Text] [Related]

  • 19. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA, López AG, Pérez Y, Cos P, Froeyen M.
    Parasitol Res; 2019 May 03; 118(5):1533-1548. PubMed ID: 30903349
    [Abstract] [Full Text] [Related]

  • 20. Genetics. Leishmania exploit sex.
    Miles MA, Yeo M, Mauricio IL.
    Science; 2009 Apr 10; 324(5924):187-9. PubMed ID: 19359570
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.